Silver nanoparticles (AgNPs) and AgNO3 perturb the specification of human hepatocyte-like cells and cardiomyocytes
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Science of The Total Environment
- Vol. 725, 138433
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Sciences
- National Natural Science Foundation of China
- K. C. Wong Education Foundation
This publication has 61 references indexed in Scilit:
- Argyria - Case reportAnais Brasileiros de Dermatologia, 2013
- Silver nanoparticles are broad-spectrum bactericidal and virucidal compoundsJournal of Nanobiotechnology, 2011
- Silver Nanoparticles Compromise Neurodevelopment in PC12 Cells: Critical Contributions of Silver Ion, Particle Size, Coating, and CompositionEnvironmental Health Perspectives, 2011
- Silver nanoparticle applications and human healthClinica Chimica Acta, 2010
- Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryosNanotoxicology, 2010
- A regulatory pathway involving Notch1/β-catenin/Isl1 determines cardiac progenitor cell fate.Nature Cell Biology, 2009
- Silver nanoparticles as a new generation of antimicrobialsBiotechnology Advances, 2009
- In Vivo Imaging of Transport and Biocompatibility of Single Silver Nanoparticles in Early Development of Zebrafish EmbryosACS Nano, 2007
- The bactericidal effect of silver nanoparticlesNanotechnology, 2005
- STUDIES IN HEPATIC GLYCOGEN STORAGE: I. ADRENALIN-INDUCED HYPERGLYCEMIA AS AN INDEX OF LIVER FUNCTIONThe American Journal of the Medical Sciences, 1949